Literature DB >> 1887673

Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine.

A Kantele1, P H Mäkelä.   

Abstract

Human immune response to a secondary immunization by the oral route was studied by enumerating specific antibody-secreting cells (ASC) in the peripheral blood, believed to reflect the local immune response in the mucosa. The volunteers had been immunized 1-2 years earlier with live Salmonella typhi Ty21a given orally as three doses of vaccine in enteric-coated capsules (3 x E); their ASC and serum antibody responses have been published. In the present study 17 of the same volunteers received one booster dose of the same vaccine (B-E). Specific ASC appeared in the blood of all volunteers after vaccination, peaked on day 5 and faded away thereafter so that on day 9 specific ASC were detected in only seven subjects. The ASC responses to the single booster dose were significantly higher than those to one dose in primary immunization and at least as high as those of the same volunteers to three doses in primary immunization. Serum antibody responses were not seen in any of the vaccinees after secondary immunization, whereas after primary immunization 60% of these subjects responded. This study shows the presence of immunologic memory also in respect of the human ASC response, and confirms the separate nature of ASC and serum response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1887673     DOI: 10.1016/0264-410x(91)90129-t

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.

Authors:  D M Hone; C O Tacket; A M Harris; B Kay; G Losonsky; M M Levine
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 2.  Enteric infections, diarrhea, and their impact on function and development.

Authors:  William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

3.  Validation of a gastrointestinal explant system for measurement of mucosal antibody production.

Authors:  G A Losonsky; G T Fantry; M Reymann; Y Lim
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria.

Authors:  J F Viret; D Favre; B Wegmüller; C Herzog; J U Que; S J Cryz; A B Lang
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

5.  Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain.

Authors:  D Nardelli-Haefliger; J P Kraehenbuhl; R Curtiss; F Schodel; A Potts; S Kelly; P De Grandi
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

6.  T- and B-cell immune responses of patients who had undergone colectomies to oral administration of Salmonella enterica serovar Typhi Ty21a vaccine.

Authors:  Jan Kilhamn; Samuel B Lundin; Hans Brevinge; Ann-Mari Svennerholm; Marianne Jertborn
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

7.  Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.

Authors:  G A Losonsky; C O Tacket; S S Wasserman; J B Kaper; M M Levine
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

8.  Local immune response to upper urinary tract infections in children.

Authors:  Anu Kantele; Nina Palkola; Heikki Arvilommi; Olli Honkinen; Timo Jahnukainen; Jussi Mertsola; Jussi M Kantele
Journal:  Clin Vaccine Immunol       Date:  2008-01-09

Review 9.  Vaccination against typhoid fever: present status.

Authors:  B Ivanoff; M M Levine; P H Lambert
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

10.  Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.

Authors:  Anu Kantele; Sari H Pakkanen; Riitta Karttunen; Jussi M Kantele
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.